DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹829 Cr | ₹1,891 Cr | ₹-376 Cr | ₹-2,686 Cr | ₹-242 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR REDDYS LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹829 Cr |
| Mar2025 | ₹1,891 Cr |
| Mar2024 | ₹-376 Cr |
| Mar2023 | ₹-2,686 Cr |
| Mar2022 | ₹-242 Cr |
How is Cash Flow from Financing Activities of DR REDDYS LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹829 Cr | -56.16 | |
| Mar2025 | ₹1,891 Cr | Positive | |
| Mar2024 | ₹-376 Cr | Negative | |
| Mar2023 | ₹-2,686 Cr | Negative | |
| Mar2022 | ₹-242 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹99,755.0 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| MANKIND PHARMA | ₹97,850.4 Cr | -4.5% | 2.7% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -1.1% |
3.8% |
-5.5% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses